Remove neurotechs-vision-loss-cell-therapy-implant-hits-primary-goals-phase-3-trials
article thumbnail

Neurotech's vision loss cell therapy implant hits primary goals in phase 3 trials

Fierce Pharma

Neurotech's vision loss cell therapy implant hits primary goals in phase 3 trials. Tue, 11/08/2022 - 06:28.

261
261